Showing results (831-840 of 2,331) with videos related to
Sort By:
Pageof 234
Clinical Drug Investigation|May 4, 2012
Leukaemic transformation in patients with haematological disease receiving tumour necrosis factor inhibitorsFrancisca Ferrer-Marín, Maria Luz Amigo, Vicente VicenteClinical Drug Investigation|December 29, 2011
Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysisLidia Brydak, Julie Roiz, Pascaline Faivre, et al.Clinical Drug Investigation|November 26, 2011
Monthly administration of a continuous erythropoietin receptor activator provides efficient haemoglobin control in non-dialysis patients during routine clinical practice: results from the non-interventional, single-cohort, multicentre, SUPRA studyStefan Heidenreich, Frank Leistikow, Stefan Zinn, et al.Clinical Drug Investigation|December 2, 2011
Dose proportionality and pharmacokinetics of fentanyl buccal soluble film in healthy subjects: a phase I, open-label, three-period, crossover studyAndrew L Finn, Niraj Vasisht, Jeffrey G Stark, et al.Clinical Drug Investigation|August 15, 2013
Safety and tolerability of an intra-seasonal initiation of the SQ-standardised grass allergy immunotherapy tablet: a non-interventional observational study investigating the feasibility during routine administrationJan-Alexander Schwab, Hendrik Wolf, Jörg Schnitker, et al.Clinical Drug Investigation|August 28, 2013
Safety of bevacizumab in treating metastatic colorectal cancer: a systematic review and meta-analysis of all randomized clinical trialsFei Dai, Lixing Shu, Yangfang Bian, et al.Clinical Drug Investigation|October 1, 2011
Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: focus on bile acid sequestrantsJens Juul Holst, Maria A McGillClinical Drug Investigation|September 1, 2011
Effect of Ipragliflozin (ASP1941), a novel selective sodium-dependent glucose co-transporter 2 inhibitor, on urinary glucose excretion in healthy subjectsStephan A Veltkamp, Takeshi Kadokura, Walter J J Krauwinkel, et al.Clinical Drug Investigation|November 1, 2011
Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phaseDomenic Sica, Alan H Gradman, Ole Lederballe, et al.Clinical Drug Investigation|October 22, 2011
Bupropion in the treatment of major depressive disorder in real-life practiceDiogo Azevedo Oliveira Sennfelt, Maria Alice Rodrigues Marques da Silva, Anabela Pereira da Silva TavaresPageof 234